We are live on ! Find out more
N

Nuveen Portfolio holdings

AUM $369B
1-Year Est. Return 31.66%
This Fund
S&P 500
This Quarter Est. Return
+15.99%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$362B
AUM Growth
+$32.2B
Cap. Flow
+$418M
Cap. Flow %
0.12%
Top 10 Hldgs %
32.89%
Holding
3,469
New
192
Increased
989
Reduced
1,979
Closed
199

Sector Composition

Rank Sector Weight
1 Technology 32.82%
2 Financials 13.01%
3 Consumer Discretionary 11.23%
4 Communication Services 9.04%
5 Industrials 8.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TLYS icon
3376
Tilly's
TLYS
$115M
-61,845
Closed -$136K
TNYA icon
3377
Tenaya Therapeutics
TNYA
$168M
-226,202
Closed -$129K
TPIC
3378
DELISTED
TPI Composites
TPIC
-43,078
Closed -$34.7K
TSQ icon
3379
Townsquare Media
TSQ
$113M
-16,995
Closed -$138K
TWIN icon
3380
Twin Disc
TWIN
$335M
-15,002
Closed -$114K
ULBI icon
3381
Ultralife
ULBI
$88.3M
-21,647
Closed -$116K
UP icon
3382
Wheels Up
UP
$220M
-7,351
Closed -$148K
URG
3383
Ur-Energy
URG
$485M
-800,049
Closed -$539K
VERU icon
3384
Veru
VERU
$36.1M
-17,856
Closed -$87.5K
VRA icon
3385
Vera Bradley
VRA
$105M
-48,692
Closed -$110K
VTSI icon
3386
VirTra
VTSI
$35.9M
-23,041
Closed -$93.8K
VTYX
3387
DELISTED
Ventyx Biosciences
VTYX
-168,420
Closed -$194K
WOLF icon
3388
Wolfspeed
WOLF
$1.2B
-451,818
Closed -$1.36M
X
3389
DELISTED
US Steel
X
-582,651
Closed -$24.6M
XBI icon
3390
State Street SPDR S&P Biotech ETF
XBI
$10.1B
-149,658
Closed -$12.1M
XBIT icon
3391
XBiotech
XBIT
$69.2M
-24,879
Closed -$80.6K
ZNTL icon
3392
Zentalis Pharmaceuticals
ZNTL
$308M
-507,527
Closed -$807K
ZURA icon
3393
Zura Bio
ZURA
$497M
-58,961
Closed -$76.1K
ZYXI
3394
DELISTED
Zynex
ZYXI
-49,860
Closed -$110K
FBLG icon
3395
FibroBiologics
FBLG
$4.33M
-1,727
Closed -$31.1K
ANRO icon
3396
Alto Neuroscience
ANRO
$1.04B
-139,953
Closed -$302K
GUTS icon
3397
Fractyl Health
GUTS
$123M
-72,958
Closed -$86.8K
KYTX icon
3398
Kyverna Therapeutics
KYTX
$450M
-47,508
Closed -$91.7K
MGX icon
3399
Metagenomi Therapeutics
MGX
$45.4M
-63,248
Closed -$86K
TELO icon
3400
Telomir Pharmaceuticals
TELO
$79.1M
-24,990
Closed -$80.7K

Similar funds

Nuveen's Q2 2025 Portfolio in Review

As of Q2 2025, Nuveen held 3,469 positions worth $362B, up 9.8% from $330B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Nuveen's Q2 2025 filing shows 192 new, 989 increased, 1,979 reduced and 199 closed positions. Its largest new stake was Janus Henderson AAA CLO ETF: 4,258,000 shares worth $216M. The largest sale was Nuveen Growth Opportunities ETF, an estimated $2.48B.

By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 28% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Nuveen's largest Q2 2025 buy was Janus Henderson AAA CLO ETF: 4,258,000 shares worth $216M.
  • Nuveen added most to Meta Platforms (Facebook) in Q2 2025, an estimated $5.9B increase.
  • Nuveen's biggest Q2 2025 reduction was Cintas, cutting an estimated $1.73B.
  • Nuveen fully exited Nuveen Growth Opportunities ETF in Q2 2025, selling an estimated $2.48B.
  • Nuveen's ten largest holdings make up 33% of its $362B portfolio in Q2 2025.
  • Nuveen opened 192 new positions and closed 199 in Q2 2025.
  • Nuveen's portfolio value rose 9.8% quarter-over-quarter to $362B.

Based on Nuveen's 13F filing for Q2 2025, filed 12 Aug 2025.